Sept 9 (Reuters) -
* COVID-19 VACCINE TRIAL PARTICIPANT HAD SERIOUS NEUROLOGICAL SYMPTOMS, BUT COULD BE DISCHARGED TODAY, ASTRAZENECA CEO SAYS - STAT NEWS Source text: https://bit.ly/32drBVO Further company coverage:
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11,994 GBX | -0.27% | +9.56% | +13.13% |
10:34am | Peel Hunt cuts ConvaTec to 'reduce' | AN |
10:23am | THE FTSE 100 is on a roll |
Sept 9 (Reuters) -
* COVID-19 VACCINE TRIAL PARTICIPANT HAD SERIOUS NEUROLOGICAL SYMPTOMS, BUT COULD BE DISCHARGED TODAY, ASTRAZENECA CEO SAYS - STAT NEWS Source text: https://bit.ly/32drBVO Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+13.13% | 233B | |
+24.84% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+5.23% | 201B | |
-10.14% | 193B | |
-12.26% | 143B | |
-6.47% | 144B | |
+1.50% | 123B |